SDI Limited (ASX:SDI) Catches Investor Attention on $1.40 Sinocera Takeover Scheme Becomes Effective

Sonal Goyal

25 June 2026 03:25 PM AEST

SDI Limited (ASX:SDI) Catches Investor Attention on $1.40 Sinocera Takeover Scheme Becomes Effective

Image Source: shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

SDI Limited (ASX: SDI) has confirmed that the scheme of arrangement for its acquisition by a Sinocera-controlled entity has become Effective.
Shareholders are set to receive A$1.40 cash per SDI share under the scheme consideration.
Quotation of SDI shares on the ASX will be suspended from the close of trading on 25 June 2026.
Implementation is expected on Monday 6 July 2026, with a record date of 7:00pm (Sydney) on Monday 29 June 2026.
All dates remain indicative and subject to change, the company advised in its announcement.

Australian investors tracking healthcare and dental-sector deals received a significant market update on 25 June 2026, when SDI Limited (ASX: SDI) released an ASX announcement confirming that the scheme of arrangement under which the company is to be acquired had become Effective. The development represents one of the closing milestones in a takeover process that values the long-established Australian dental materials manufacturer at A$1.40 per share in cash.

The company announcement followed approval of the scheme by the Supreme Court of New South Wales, a step that paved the way for the deal to move toward completion. With the scheme now Effective, attention among Australian investors and market watchers turns to the practical mechanics of the transaction, including the impending trading suspension of SDI shares and the timetable for payment of the scheme consideration. This ASX company news matters not only to existing holders of the ASX stock but also to those following consolidation across the global dental and healthcare landscape.

For an ASX ticker that has traded on the Australian market for decades, the move toward delisting under a foreign-led acquisition marks a notable chapter. This article sets out the facts disclosed in the investor update, places the deal in its sector context, and outlines what shareholders and observers may watch as the process advances.

Company Overview

SDI Limited is a leading Australian manufacturer and global distributor of specialist dental materials. The company's product range spans restorative dental products, including amalgams, composites, adhesives, cements and tooth-whitening systems. These materials are used by dental professionals in a variety of clinical applications, positioning SDI within the broader healthcare supply chain.

A distinguishing feature of the business is its manufacturing footprint: all of SDI's products are manufactured in Victoria, Australia, and distributed in more than 100 countries. This combination of domestic production and international reach has underpinned the company's profile as an Australian exporter within a specialised niche of the dental sector.

SDI was founded in 1972 and became publicly listed in 1985, giving it a presence on the Australian market spanning roughly four decades. Over that period it has built a reputation as a focused player in dental consumables, a category that sits at the intersection of manufacturing and healthcare.

The acquirer side of the transaction involves a structured chain of entities. The bidder, Beijing Guoci Kebo Technology Co., Ltd, is an entity controlled by Shandong Sinocera Functional Material Co. Ltd, which is listed on the Shenzhen Stock Exchange. Sinocera is described as a China-based advanced and functional ceramic materials company serving the electronics, automotive and healthcare industries. Beijing Guoci holds the majority of Sinocera's domestic and international dental businesses, and the acquisition of SDI would be undertaken through InnoXvest Dental Pty Ltd, a wholly owned subsidiary of the bidder acting as the bidder sub.

Announcement Summary

In its 25 June 2026 ASX announcement, SDI Limited confirmed that the scheme of arrangement under which it is to be acquired has become Effective. Under the scheme, InnoXvest Dental Pty Ltd, the bidder sub and a wholly owned subsidiary of Beijing Guoci Kebo Technology Co., Ltd, will acquire 100% of SDI's issued share capital for A$1.40 per SDI share in cash, an amount described as the scheme consideration.

The pathway to the scheme becoming Effective ran through the courts. The Supreme Court of New South Wales approved the scheme, and SDI lodged an office copy of the Court orders with the Australian Securities and Investments Commission under section 411(10) of the Corporations Act 2001 (Cth). The lodgement of those orders is what renders the scheme Effective, a key procedural threshold in an Australian scheme of arrangement.

With the scheme now Effective, SDI advised that quotation of its shares on the ASX will be suspended from the close of trading on 25 June 2026. The transaction is being progressed in line with the Scheme Booklet dated 18 May 2026, and the announcement was authorised for release by the SDI Board.

Key Details from the Announcement

The following key details were disclosed in the SDI company announcement:

Scheme consideration: A$1.40 in cash per SDI share, payable to eligible shareholders.
Acquiring structure: InnoXvest Dental Pty Ltd (bidder sub), a wholly owned subsidiary of Beijing Guoci Kebo Technology Co., Ltd (bidder), an entity controlled by Shenzhen Stock Exchange-listed Shandong Sinocera Functional Material Co. Ltd, will acquire 100% of SDI's issued share capital.
Court approval: The Supreme Court of New South Wales approved the scheme, with an office copy of the Court orders lodged with ASIC under section 411(10) of the Corporations Act 2001 (Cth).
Trading suspension: Quotation of SDI shares on the ASX will be suspended from the close of trading on 25 June 2026.
Record date: Shareholders recorded on the register at 7:00pm (Sydney) on Monday 29 June 2026 will be entitled to the scheme consideration.
Implementation date: Implementation is expected on Monday 6 July 2026, when eligible shareholders will receive A$1.40 cash per SDI share.
Advisers: SDI is advised by Houlihan Lokey as financial adviser and DLA Piper as legal adviser.
Governing documents: The transaction is documented in the Scheme Booklet dated 18 May 2026, and the announcement was authorised by the SDI Board.

SDI also noted that all dates referenced in the announcement are indicative and subject to change. The company did not specify any revised dates beyond the timetable disclosed.

Why This Matters for ASX Investors

For Australian investors, the confirmation that the scheme is Effective is a meaningful milestone in the transaction. In an ASX scheme of arrangement, the scheme becoming Effective signals that the principal regulatory and court conditions have been satisfied, and that the deal is moving into its implementation phase. This stage typically carries reduced completion risk compared with the earlier stages of a takeover, although the company stressed that the remaining dates are indicative.

The trading suspension is a practical consequence that directly affects holders of the ASX stock. From the close of trading on 25 June 2026, SDI shares will no longer be quoted on the ASX, meaning shareholders will not be able to trade their holdings on market after that point. Instead, the value of those holdings is set to be realised through the scheme consideration rather than through on-market transactions.

The fixed cash price of A$1.40 per share provides clarity on the amount that eligible shareholders are scheduled to receive. For ASX shares being acquired by way of scheme, a defined cash figure removes some of the pricing uncertainty that can accompany market-traded securities. Investors following this market update may note that the consideration is payable in cash, as set out in the announcement.

More broadly, the deal is an example of inbound interest in Australian healthcare and dental assets. Such transactions can be of interest to Australian investors monitoring acquisition activity, foreign investment in domestic manufacturers, and the broader theme of consolidation within the dental sector.

Sector Context

SDI operates within the dental materials segment of the healthcare industry, a specialised area that combines manufacturing expertise with clinical end-use. Dental consumables such as composites, adhesives, cements and tooth-whitening systems serve practitioners across a wide range of markets, and SDI's distribution into more than 100 countries underscores the global nature of demand for these products.

The acquirer, Sinocera, is described as an advanced and functional ceramic materials company that serves electronics, automotive and healthcare customers. Its subsidiary Beijing Guoci holds the majority of Sinocera's domestic and international dental businesses, suggesting that the acquisition of SDI would align with an existing strategic focus on dental products. The combination brings together an Australian manufacturer with established global distribution and a larger international group with a stated presence in the dental space.

Cross-border acquisitions of this kind reflect ongoing interest in the healthcare and dental sectors from international buyers. For followers of stock market news, deals involving the takeover of an established ASX company by an overseas-controlled entity can offer insight into how global players are seeking exposure to specialised manufacturing and healthcare supply chains. The transaction also illustrates the role that the scheme of arrangement mechanism plays in facilitating change-of-control transactions on the Australian market.

Possible Market Reaction

Because SDI shares are scheduled to be suspended from quotation at the close of trading on 25 June 2026, the window for on-market reaction to this announcement is limited. Once suspended, the ASX ticker will no longer reflect live market pricing, and the focus shifts from share-price movement to the delivery of the scheme consideration.

In transactions where a scheme has become Effective and a fixed cash price applies, market pricing in the lead-up to suspension often trades close to the consideration amount, reflecting the high likelihood of completion. Investors may watch how SDI shares behave in any remaining trading session before suspension, while bearing in mind that the company has not made any forecast about share-price behaviour. This article makes no prediction about whether the price will rise or fall.

After suspension, the primary event for shareholders is the scheduled receipt of A$1.40 cash per share on the indicative implementation date. Investors may watch announcements from SDI for confirmation that implementation has occurred and that payment has been processed in line with the disclosed timetable.

Risks and Uncertainties

While the scheme becoming Effective is an important milestone that reduces completion risk, several uncertainties remain that Australian investors may consider. First, the company expressly stated that all dates in the announcement, including the record date of 29 June 2026 and the expected implementation date of 6 July 2026, are indicative and subject to change. Any adjustment to the timetable could affect when shareholders receive the scheme consideration.

Second, scheme implementation involves procedural and administrative steps between the scheme becoming Effective and the actual transfer of shares and payment of consideration. Although the major court and regulatory thresholds have been met, the practical completion of these steps remains a part of the process. The company did not specify any outstanding conditions beyond what is set out in the announcement and the Scheme Booklet dated 18 May 2026.

Third, the transaction involves a change of control to an entity controlled by an overseas-listed company, Shandong Sinocera Functional Material Co. Ltd, listed on the Shenzhen Stock Exchange. Foreign ownership of an Australian manufacturer can be a relevant consideration for stakeholders observing such deals. The announcement did not specify any further regulatory matters beyond the court approval and ASIC lodgement already disclosed, and readers should refer to the Scheme Booklet for the complete terms.

Because the scheme is approved and Effective, the likelihood of the transaction not completing is reduced relative to earlier stages. Nonetheless, investors should treat the disclosed dates as indicative and rely on official company announcements for confirmation of each step.

What to Watch Next

Investors and observers following this investor update may watch for several upcoming developments in the SDI takeover process:

Confirmation of the trading suspension taking effect from the close of trading on 25 June 2026.
The record date at 7:00pm (Sydney) on Monday 29 June 2026, which determines the shareholders entitled to the scheme consideration.
Implementation on the expected date of Monday 6 July 2026, including payment of A$1.40 cash per SDI share to eligible shareholders.
Any further ASX announcements from SDI confirming completion of implementation or any changes to the indicative timetable.
The eventual removal of SDI from the official list of the ASX following implementation, as is typical once a scheme of arrangement completes.

As with any company announcement, the company did not specify matters beyond those disclosed, and investors may rely on official releases for updates.

Conclusion

The 25 June 2026 ASX announcement from SDI Limited confirms that the scheme of arrangement for its acquisition by a Sinocera-controlled entity has become Effective, marking a decisive step toward completion of the A$1.40 per share cash takeover. With the Supreme Court of New South Wales having approved the scheme and the Court orders lodged with ASIC, the transaction has cleared its principal court and regulatory thresholds.

For Australian investors, the immediate consequences are clear: SDI shares are set to be suspended from quotation on the ASX from the close of trading on 25 June 2026, the record date falls at 7:00pm (Sydney) on 29 June 2026, and implementation is expected on 6 July 2026, subject to the company's note that all dates are indicative. The deal brings together a four-decade-old Australian dental manufacturer with an internationally focused materials group, and stands as a notable example of acquisition activity in the dental and healthcare space.

As the process moves toward implementation, holders of the ASX stock and other market watchers may follow official SDI announcements for confirmation of each milestone. This market update underscores how the scheme of arrangement mechanism continues to facilitate change-of-control transactions on the Australian market.

FAQs

Q: What has SDI Limited announced?

A: SDI Limited (ASX: SDI) announced on 25 June 2026 that the scheme of arrangement under which it is to be acquired has become Effective. The acquisition values the company at A$1.40 per SDI share in cash.

Q: Who is acquiring SDI Limited?

A: SDI is to be acquired by InnoXvest Dental Pty Ltd, a wholly owned subsidiary of Beijing Guoci Kebo Technology Co., Ltd. The bidder is an entity controlled by Shandong Sinocera Functional Material Co. Ltd, which is listed on the Shenzhen Stock Exchange. The acquirer will take 100% of SDI's issued share capital.

Q: How much will SDI shareholders receive?

A: Eligible shareholders are scheduled to receive A$1.40 in cash per SDI share, described as the scheme consideration. Shareholders recorded on the register at 7:00pm (Sydney) on Monday 29 June 2026 are entitled to this amount.

Q: When will SDI shares be suspended from the ASX?

A: Quotation of SDI shares on the ASX will be suspended from the close of trading on 25 June 2026. After this point, shares will no longer be tradeable on market.

Q: When is the transaction expected to be implemented?

A: Implementation is expected on Monday 6 July 2026, when eligible shareholders are scheduled to receive the cash consideration. SDI noted that all dates are indicative and subject to change.

Q: Why has SDI become a takeover target?

A: The announcement did not specify the strategic rationale in detail beyond confirming the deal terms. SDI is a long-established Australian dental materials manufacturer, and the acquirer's subsidiary holds the majority of Sinocera's dental businesses, indicating alignment within the dental sector. Readers should refer to the Scheme Booklet dated 18 May 2026 for further information.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.